Michael Channing Lyon
Engineers at Pennsylvania Ave, Boulder, CO
License number
Colorado 68036
Issued Date
Jun 29, 2012
Renew Date
Jun 29, 2012
Type
Engineer Intern
Address
Address
2910 Pennsylvania Ave, Boulder, CO 80303
Professional information
Pyrrolopyridines As Kinase Inhibitors
US Patent:
8178131, May 15, 2012
Filed:
May 13, 2009
Appl. No.:
12/992468
Inventors:
Yvan Le Huerou - Boulder CO, US
James F. Blake - Boulder CO, US
Indrani W. Gunawardana - Boulder CO, US
Peter J. Mohr - Boulder CO, US
Eli M. Wallace - Boulder CO, US
Bin Wang - Boulder CO, US
Mark Joseph Chicarelli - Boulder CO, US
Michael Lyon - Boulder CO, US
James F. Blake - Boulder CO, US
Indrani W. Gunawardana - Boulder CO, US
Peter J. Mohr - Boulder CO, US
Eli M. Wallace - Boulder CO, US
Bin Wang - Boulder CO, US
Mark Joseph Chicarelli - Boulder CO, US
Michael Lyon - Boulder CO, US
Assignee:
Array BioPharma Inc. - Boulder CO
International Classification:
A61K 33/24, A61K 31/437, A61K 31/7068, A61K 31/4745, A61K 31/513, A61K 31/497, A61K 31/506, A61K 31/501, A61K 31/498, A61K 31/5377, A61K 31/55, A61P 35/00, C07D 471/04
US Classification:
424649, 51421018, 51421021, 51421707, 5142328, 514249, 51425201, 51425505, 514256, 514274, 514283, 514300, 514 49, 540597, 544127, 544238, 544333, 544355, 544405, 546113
Abstract:
Compounds of Formula (I) are useful for inhibition of CHK1 and/or CHK2. Methods of using compounds of Formula (I) and stereoisomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.
Pyrrolopyridines As Kinase Inhibitors
US Patent:
8545897, Oct 1, 2013
Filed:
Mar 20, 2012
Appl. No.:
13/425186
Inventors:
Yvan Le Huerou - Boulder CO, US
James F. Blake - Boulder CO, US
Indrani W. Gunwardana - Boulder CO, US
Pete Mohr - Boulder CO, US
Eli M. Wallace - Boulder CO, US
Bin Wang - Boulder CO, US
Mark Joseph Chicarelli - Boulder CO, US
Michael Lyon - Boulder CO, US
James F. Blake - Boulder CO, US
Indrani W. Gunwardana - Boulder CO, US
Pete Mohr - Boulder CO, US
Eli M. Wallace - Boulder CO, US
Bin Wang - Boulder CO, US
Mark Joseph Chicarelli - Boulder CO, US
Michael Lyon - Boulder CO, US
Assignee:
Array BioPharma Inc. - Boulder CO
International Classification:
A61K 31/4545, A61K 31/437, A61K 31/497, A61K 31/506, A61K 33/24, A61K 31/513, A61K 31/444, A61K 31/501, A61P 35/00
US Classification:
424649, 51421018, 51421021, 514249, 51425204, 51425505, 514256, 514274, 514278, 514283, 514300, 514 49
Abstract:
Compounds of Formula I are useful for inhibition of CHK1 and/or CHK2. Methods of using compounds of Formula I and stereoisomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.